Description

TIR is a new research peptide combining the properties of GLP-1 and GIP, showing strong potential in studies related to body-weight regulation, glycemic control, and metabolic health. It acts through mechanisms such as glucose-dependent insulin secretion, glucagon modulation, and appetite regulation. In laboratory and preclinical models, these pathways are analyzed for their role in weight management and lipid metabolism. Early scientific data also explore its relevance to cardiovascular function, kidney support, and beta-cell activity.

Research indicates that the peptide may also be evaluated for its neuroprotective properties, including studies involving oxidative stress and inflammatory responses in neural tissue. Additionally, TIR is examined in research related to gastrointestinal health, including intestinal motility, microbiota balance, and barrier integrity. Due to its broad research profile, TIR is considered a promising subject of investigation in the fields of obesity, type 2 diabetes, and metabolic disorders.

Laboratory Reagent – For Research Purposes Only
This product is classified as a chemical reagent exclusively for research purposes and should be handled by qualified professionals in laboratory conditions. It is not a dietary supplement, medicine, or food product and is not intended for human consumption. All information provided is for educational and scientific purposes only.